Therapeutic Asset Ratings
5,108 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Surovatamig
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
AstraZeneca
P3
BB
(66)
Tabelecleucel
Epstein-Barr Virus-Associated Lymphoproliferative Disorder
Pierre Fabre Medicament
P3
BB
(66)
Tabelecleucel
Disease Related To Hematopoietic Stem Cell Transplant
Pierre Fabre Medicament
P3
BB
(66)
TACROLIMUS
Acute Biphenotypic Leukemia
St. Petersburg State Pavlov Medical University
P3
BB
(66)
TACROLIMUS
Acute Myeloid Leukemia
City of Hope Medical Center
P3
BB
(66)
TACROLIMUS
Childhood Acute Lymphoblastic Leukemia
Clarteis
P3
BB
(66)
TACROLIMUS
Myeloproliferative Neoplasm
Stanford University
P3
BB
(66)
TACROLIMUS
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P3
BB
(66)
TAMOXIFEN
Ovarian Carcinoma
OHSU Knight Cancer Institute
P3
BB
(66)
TAMOXIFEN
Lobular Breast Carcinoma In Situ
National Cancer Institute (NCI)
P3
BB
(66)
Tas-205
Duchenne Muscular Dystrophy
Taiho Pharmaceutical Co., Ltd.
P3
BB
(66)
Tebentafusp
Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute
P3
BB
(66)
Tenecteplase
Intracerebral Hemorrhage
Gaurav Gupta, MD
P3
BB
(66)
THIOGUANINE ANHYDROUS
T-Lymphoblastic Lymphoma
Children's Oncology Group
P3
BB
(66)
Tifcemalimab
Small Cell Lung Carcinoma
Sichuan University
P3
BB
(66)
Tirabrutinib
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.
P3
BB
(66)
Tisagenlecleucel
Non-Hodgkin Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
P3
BB
(66)
Toripalimab
Extranodal Nasal NK/T Cell Lymphoma
Beijing Tongren Hospital
P3
BB
(66)
tqb3616
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
BB
(66)
(±)-Tramadol
Neuralgia
Aretaieion University Hospital
P3
BB
(66)
Tranexamic Acid
Injury
Daniel Nishijima, MD, MAS
P3
BB
(66)
TRASTUZUMAB
Colon Adenocarcinoma
IFOM ETS - The AIRC Institute of Molecular Oncology
P3
BB
(66)
TRASTUZUMAB
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer Institute
P3
BB
(66)
Trastuzumab Emtansine
Breast Cancer
SWOG Cancer Research Network
P3
BB
(66)
Trastuzumab Emtansine
Breast Carcinoma
SWOG Cancer Research Network
P3
BB
(66)
Showing 1351 to 1375 of 5,108 assets
Previous
Page 55 of 205
Next